Clinical Trial Update: Studying Biomarkers in Samples From Patients With Rhabdomyosarcoma

View source ↗

Summary

A completed clinical trial update focusing on biomarkers in samples from patients with rhabdomyosarcoma, conducted by the Children's Oncology Group.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhabdomyosarcoma

Snippet

Sponsor: Children's Oncology Group | Conditions: Sarcoma | Status: COMPLETED